253 related articles for article (PubMed ID: 24875055)
1. A novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved "knob" region of VP3 protein.
Kiener TK; Jia Q; Meng T; Chow VT; Kwang J
PLoS Negl Trop Dis; 2014; 8(5):e2895. PubMed ID: 24875055
[TBL] [Abstract][Full Text] [Related]
2. Characterization and specificity of the linear epitope of the enterovirus 71 VP2 protein.
Kiener TK; Jia Q; Lim XF; He F; Meng T; Chow VT; Kwang J
Virol J; 2012 Feb; 9():55. PubMed ID: 22361222
[TBL] [Abstract][Full Text] [Related]
3. Effective in vivo therapeutic IgG antibody against VP3 of enterovirus 71 with receptor-competing activity.
Jia Q; Ng Q; Chin W; Meng T; Chow VTK; Wang CI; Kwang J; He F
Sci Rep; 2017 Apr; 7():46402. PubMed ID: 28422137
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P
Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643
[TBL] [Abstract][Full Text] [Related]
5. Characterization of an isotype-dependent monoclonal antibody against linear neutralizing epitope effective for prophylaxis of enterovirus 71 infection.
Lim XF; Jia Q; Khong WX; Yan B; Premanand B; Alonso S; Chow VT; Kwang J
PLoS One; 2012; 7(1):e29751. PubMed ID: 22279543
[TBL] [Abstract][Full Text] [Related]
6. A new EV71 VP3 epitope in norovirus P particle vector displays neutralizing activity and protection in vivo in mice.
Jiang L; Fan R; Sun S; Fan P; Su W; Zhou Y; Gao F; Xu F; Kong W; Jiang C
Vaccine; 2015 Nov; 33(48):6596-603. PubMed ID: 26529072
[TBL] [Abstract][Full Text] [Related]
7. Structural and functional analysis of protective antibodies targeting the threefold plateau of enterovirus 71.
Huang KA; Zhou D; Fry EE; Kotecha A; Huang PN; Yang SL; Tsao KC; Huang YC; Lin TY; Ren J; Stuart DI
Nat Commun; 2020 Oct; 11(1):5253. PubMed ID: 33067459
[TBL] [Abstract][Full Text] [Related]
8. Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon.
Tian X; Su X; Li X; Li H; Li T; Zhou Z; Zhong T; Zhou R
PLoS One; 2012; 7(7):e41381. PubMed ID: 22848478
[TBL] [Abstract][Full Text] [Related]
9. Immunological evaluation and comparison of different EV71 vaccine candidates.
Chou AH; Liu CC; Chang JY; Lien SP; Guo MS; Tasi HP; Hsiao KN; Liu SJ; Sia C; Wu SC; Lee MS; Hsiao CH; Wang JR; Chow YH; Chong P
Clin Dev Immunol; 2012; 2012():831282. PubMed ID: 23008736
[TBL] [Abstract][Full Text] [Related]
10. Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps.
Ku Z; Ye X; Huang X; Cai Y; Liu Q; Li Y; Su Z; Huang Z
PLoS One; 2013; 8(2):e57601. PubMed ID: 23451250
[TBL] [Abstract][Full Text] [Related]
11. Single Neutralizing Monoclonal Antibodies Targeting the VP1 GH Loop of Enterovirus 71 Inhibit both Virus Attachment and Internalization during Viral Entry.
Ku Z; Ye X; Shi J; Wang X; Liu Q; Huang Z
J Virol; 2015 Dec; 89(23):12084-95. PubMed ID: 26401034
[TBL] [Abstract][Full Text] [Related]
12. Structures of Coxsackievirus A16 Capsids with Native Antigenicity: Implications for Particle Expansion, Receptor Binding, and Immunogenicity.
Ren J; Wang X; Zhu L; Hu Z; Gao Q; Yang P; Li X; Wang J; Shen X; Fry EE; Rao Z; Stuart DI
J Virol; 2015 Oct; 89(20):10500-11. PubMed ID: 26269176
[TBL] [Abstract][Full Text] [Related]
13. Determinants of EV71 immunogenicity and protection against lethal challenge in a mouse model.
Chang J; Li J; Wei W; Liu X; Liu G; Yang J; Zhang W; Yu XF
Immunol Res; 2015 Jul; 62(3):306-15. PubMed ID: 26025091
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of neutralization epitopes at VP2 and VP1 of enterovirus A71.
NikNadia N; Tan CW; Ong KC; Sam IC; Chan YF
J Med Virol; 2018 Jun; 90(6):1164-1167. PubMed ID: 29457642
[TBL] [Abstract][Full Text] [Related]
15. Structural Basis for Recognition of Human Enterovirus 71 by a Bivalent Broadly Neutralizing Monoclonal Antibody.
Ye X; Fan C; Ku Z; Zuo T; Kong L; Zhang C; Shi J; Liu Q; Chen T; Zhang Y; Jiang W; Zhang L; Huang Z; Cong Y
PLoS Pathog; 2016 Mar; 12(3):e1005454. PubMed ID: 26938634
[TBL] [Abstract][Full Text] [Related]
16. Development of a sensitive and specific epitope-blocking ELISA for universal detection of antibodies to human enterovirus 71 strains.
He F; Kiener TK; Lim XF; Tan Y; Raj KV; Tang M; Chow VT; Chen Q; Kwang J
PLoS One; 2013; 8(1):e55517. PubMed ID: 23383215
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies for diagnosis of enterovirus 71.
Xu L; Huang KJ; Ho TS; Liu CC; Lee YR; Lin CY; Shiuan D; Jiang XH
Monoclon Antib Immunodiagn Immunother; 2013 Dec; 32(6):386-94. PubMed ID: 24328741
[TBL] [Abstract][Full Text] [Related]
18. VP1 Amino Acid Residue 145 of Enterovirus 71 Is a Key Residue for Its Receptor Attachment and Resistance to Neutralizing Antibody during Cynomolgus Monkey Infection.
Fujii K; Sudaka Y; Takashino A; Kobayashi K; Kataoka C; Suzuki T; Iwata-Yoshikawa N; Kotani O; Ami Y; Shimizu H; Nagata N; Mizuta K; Matsuzaki Y; Koike S
J Virol; 2018 Aug; 92(15):. PubMed ID: 29848582
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of a monoclonal antibody recognizing the linear epitope RVADVI on VP1 protein of enterovirus 71.
Man-Li T; Szyporta M; Fang LX; Kwang J
J Med Virol; 2012 Oct; 84(10):1620-7. PubMed ID: 22930511
[TBL] [Abstract][Full Text] [Related]
20. Chimeric virus-like particle vaccines displaying conserved enterovirus 71 epitopes elicit protective neutralizing antibodies in mice through divergent mechanisms.
Ye X; Ku Z; Liu Q; Wang X; Shi J; Zhang Y; Kong L; Cong Y; Huang Z
J Virol; 2014 Jan; 88(1):72-81. PubMed ID: 24131712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
